A-Z page index

A B C D E F G H I J K L M N
O P Q R S T U V W X Y Z

Translate DermNet NZ

from English to German English to Spanish English to French English to Italian English to Portuguese English to Russian BETA English to Arabic BETA English to Japanese BETA English to Korean BETA English to Chinese (S) BETA

Buy skin care products

Search for books

Bullous pemphigoid

Bullous pemphigoid is a blistering skin disease which usually affects middle aged or elderly persons. It is an immunobullous disease, i.e. the blisters are due an immune reaction within the skin.

What does it look like?

Characteristically, crops of tense, fluid-filled blisters develop. They may arise from normal-looking or red patches of skin, and the blisters may be filled with clear, cloudy or blood-stained fluid. Bullous pemphigoid is usually very itchy. It may be localized to one area but is more often widespread, often favouring body folds. In severe cases, there may be blisters over the entire skin surface as well as blisters inside the mouth.

Prior to blistering, the red itchy patches may be thought to be a kind of dermatitis or urticaria.

Bullous pemphigoid

More images of bullous pemphigoid ...

How is the diagnosis made?

A dermatologist can often make the diagnosis by examining the skin carefully. In most cases the diagnosis will be confirmed by a skin biopsy of a typical blister. Under the microscope, the pathologist can see a split between the outside layer of the skin, the epidermis, and the inside layer, the dermis. Direct immunofluorescence staining highlights antibodies along the basement membrane that lies between the epidermis and dermis.

What causes bullous pemphigoid?

Bullous pemphigoid is thought to occur because IgG immunoglobulins (antibodies) and activated T lymphocytes (white blood cells) attack components of the basement membrane, particularly a protein known as the BP antigen BP180, or less frequently BP230. These proteins are within the NC16A domain of collagen XVII. BP180 is also called Type XVII collagen. These are associated with the hemidesmosomes, structures that ensure the epidermal keratinocyte cells stick to the dermis to make a waterproof seal. The ‘autoimmune’ reaction to these proteins can be thought of as a type of allergy to one's own skin.

In many patients, skin antibodies can also be detected circulating in the blood stream (positive indirect immunofluorescence).

What is the treatment?

If the pemphigoid is very widespread, hospital admission may be advised so the blisters and raw areas can be expertly dressed. Antibiotics may be required for secondary bacterial infection.

Most patients with bullous pemphigoid are treated with steroid tablets, usually prednisone. The dose is adjusted until the blisters have stopped appearing, which usually takes several weeks. The dose of prednisone is then slowly reduced over many months or years. As systemic steroids have many undesirable side effects, other medications are added to ensure the lowest possible dose (aiming for 5 to 10mg prednisone daily). These other medications may include:

• Topical steroids (usually clobetasol propionate)
• Tetracycline antibiotics
• Nicotinamide
• Dapsone
• Azathioprine
• Methotrexate
• High dose intravenous immunoglobulin

Treatment is usually needed for several years. In most cases the pemphigoid eventually completely clears up and the treatment can be stopped.

If you have pemphigoid, make sure you understand your treatment - do not alter it without consulting your dermatologist or general practitioner.